Significance of viral status on recurrence of hepatitis B-related hepatocellular carcinoma after curative therapy: A meta-analysis. (Q42439028)

31 October 2017

Significance of viral status on recurrence of hepatitis B-related hepatocellular carcinoma after curative therapy: A meta-analysis. (English)

1 reference

31 October 2017

hepatocellular carcinoma

1 reference

Li-Shuai Qu

1

1 reference

31 October 2017

Jin-Xia Liu

2

1 reference

31 October 2017

Xiao-Ling Kuai

3

1 reference

31 October 2017

Zheng-Fu Xu

4

1 reference

31 October 2017

Fei Jin

5

1 reference

31 October 2017

Guo-Xiong Zhou

6

1 reference

31 October 2017

20 June 2013

1 reference

31 October 2017

1 reference

31 October 2017

44

1 reference

31 October 2017

7

1 reference

31 October 2017

750-760

1 reference

Global cancer statistics, 2002

31 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Hepatitis B genotype C correlated with poor surgical outcomes for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Hepatocellular carcinoma and hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Etiology, natural history and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Hepatitis B virus X antigen promotes transforming growth factor-beta1 (TGF-beta1) activity by up-regulation of TGF-beta1 and down-regulation of alpha2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Prognostic factors and recurrence of hepatitis B-related hepatocellular carcinoma after argon-helium cryoablation: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

Clinical relevance of hepatitis B viral mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12172

21 January 2018

Identifiers

DOI

10.1111/HEPR.12172

1 reference

31 October 2017

1 reference